InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
4
已披露卖出
0
T+90 胜率
50%
T+90 平均收益
+9.5%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Hall Brett Matthew, Directeur Scientifique. Insider active across 1 company, notably Immuneering Corp. In total, 8 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €43k. History available since 23 March 2022. The latest transaction was disclosed on 15 January 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hall Brett Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
2,298 股@ US$4.5712.8% 占其流量Class A Common StockSEC:0001790340-26-000012:0
标准退出：2026年4月15日 (T+90)
14,880 股@ US$1.42829.3% 占其流量Class A Common StockSEC:0001790340-25-000111:0
7,415 股@ US$2.699940.0% 占其流量Class A Common StockSEC:0001790340-25-000087:0
标准退出：2025年9月18日 (T+90)
6,211 股@ US$1.6235.4% 占其流量Class A Common StockSEC:0001790340-24-000034:0
2,551 股@ US$3.9213.3% 占其流量Class A Common StockSEC:0001415889-22-005796:0
标准退出：2022年8月23日 (T+90)
1,050 股@ US$7.9110.7% 占其流量Class A Common StockSEC:0001415889-22-003305:0
标准退出：2022年6月21日 (T+90)
322,691 股Class A Common StockSEC:0001415889-21-006188:0
5,040 股Class A Common StockSEC:0001104659-21-099733:0
8 条申报中的 8 条
About Hall Brett Matthew
Hall Brett Matthew is Director Scientifique and CHIEF SCIENTIFIC OFFICER at Immuneering Corp (XNAS). He has 8 filings in total, and across the 8 sampled filings the buy amount is EUR 43294, with no sells; the period covered runs from 2021-08-04 to 2026-01-16.
